Cuffe Michael S.
- SEC CIK
- 0001632835
In the past year, 1 open-market sale filing worth $747.1K and no purchases.
Current role at each company
- HCA HCA Healthcare, Inc.EVP and Chief Clinical Officeras of Feb 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $747.1K
- 1 filing
- Net
- −$747.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Cuffe Michael S. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 (view filing) | Aug 3 | 2 days | Cuffe Michael S.President-Physician Services | SSale | −2.50K | $251.91 | −$629.8K | −12.2%17.9K after | |
| Feb 1, 2023 (view filing) | Feb 1 | Same day | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −4.00K | $257.11 | −$1.03M | −16.1%20.8K after | |
| May 2, 2023 (view filing) | Apr 28 | 4 days | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −12.6K | $284.44 | −$3.57M | −30.4%28.8K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −3.20K | $306.79 | −$981.7K | −11.4%24.9K after | |
| May 8, 2024 (view filing) | May 6 | 2 days | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −1.60K | $309.00 | −$494.4K | −4.5%34.1K after | |
| May 13, 2024 (view filing) | May 9 | 4 days | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −6.31K | $316.88 | −$2.00M | −17.6%29.6K after | |
| Sep 12, 2024 (view filing) | Sep 12 | Same day | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −8.36K | $385.42 | −$3.22M | −22.0%29.7K after | 10b5-1 |
| Sep 8, 2025 (view filing) | Sep 8 | Same day | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −3.84K | $418.84 | −$1.61M | −10.9%31.5K after | 10b5-1 |
| Feb 5, 2026 (view filing) | Feb 3 | 2 days | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −1.50K | $498.09 | −$747.1K | −4.8%30.0K after |